Pharma Marketing Network

A conversation with Rene Hansen, Global Director of Business Transformation at UCB Pharma and Benjamin Heywood, Co-founder and President of PatientsLikeMe, about the strategic partnership between UCB and PatientsLikeMe to create an online, open epilepsy community that captures real-world experiences of people living with epilepsy in the U.S.

A conversation with Kevin Kruse, President of Kru Research, presenting the results of a Twitter experiment in which a fictitious insomnia brand drug Twitter account was set up to determine the value of Twitter to reach a qualified audience of patients.

A conversation with Fard Johnmar, Founder and CEO of Envision Solutions, about an initiative to bring people working in health marketing communications together.

An ePharma Pioneer Club members-only discussion of the first-ever pharma branded Tweet. What can we learn from this? Is it a good model for other brands to follow?

A conversation with Judith von Gordon and John Pugh, external communications executives at Boehringer Ingelheim, about their use of Twitter and other social media networks.

Everyone is talking about the role of new and social media in helping pharma educate physicians and patients. Show guest, Paul Vogelzang, who is the producer of the wildly popular show, MommyCast, has helped usher branded and non-branded content sponsorships to the vast online mom audience, making MommyCast a viable forum for pharmaceutical enterprises to connect with key stakeholders.

An ePharma Pioneer Club roundtable discussion on what it's going to take to enable pharmaceutical marketers to engage in social networks without fear of adverse event reporting and other regulatory, corporate, and cultural roadblocks.

Guest Mark Bard, President Manhattan Research, in an EXCLUSIVE interview, informs listeners about the latest pharma marketing trends and emerging information technologies in Japan, China, South Korea, Taiwan, and Australia, why this knowledge is critical to pharma companies, and how it fits into a global strategy.

Guest Kim Slocum, President of KDS Consulting, LLC, and former Director, Strategic Planning & Business Development at AstraZeneca, talks about HIT mediated comparative effectiveness research as part of scenario-based strategic planning for the biopharma industry.

Guest Fabio Gratton, Co-founder, Chief Innovation Officer, Ignite Health, and ePharma Pioneer Club™ member, talks about why so few pharmaceutical companies have leveraged the power of social networks to communicate with consumers/patients and how marketers should think differently about the metrics that constitute success.